Jennifer Wo, MD,
Open to Accrual
Gastrointestinal [GI]
Liver
III
No
To determine if liver SBRT in combination with IO-based systemic therapy improves survival compared to IO-based systemic therapy alone, in patients with hepatocellular cancer with macrovascular invasion.
Diagnosis of hepatocellular cancer (HCC). HCCmacrovascular invasion, defined as enhancing vascular thrombosis demonstratingarterial enhancement and venous or delayed venous washout on multiphasic MRIand/or CT.
226
We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More
NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.